From research question to real-world product. This is the future Bio is building with BIOS.
At its core, BIOS is an AI Scientist designed to orchestrate complex biomedical research by coordinating specialized subagents across the entire scientific workflow. It is not just another AI tool, it’s the connective layer linking discovery, funding, validation, and commercialization inside the
@BioProtocol ecosystem.
Here’s how the loop works in practice.
A researcher starts with a real question. BIOS routes that question across a network of subagents. Literature agents scan PubMed, ArXiv, patents, and clinical trials. Domain-specific agents bring expertise in areas like longevity or microbiology. A novelty detection agent checks what has not been tried before. A new hypothesis emerges.
The human researcher stays in control. They refine the idea while BIOS runs simulations and in silico analysis to test feasibility. Once the signal looks promising, the project moves into a Molecule Lab, a secure, privacy-preserving data room that becomes the permanent home for the research.
Next comes validation. Funding is launched through the Bio Launchpad. The community evaluates the research. Capital flows in. Wet-lab experiments begin. Results are logged back into the Molecule Lab. BIOS continuously analyzes incoming data, suggests next steps, and enforces onchain milestones so funds are released only when real progress is made.
When the research succeeds, it doesn’t stop at a paper.
A validated compound becomes a real, shippable product through Biofy. The same BIOS infrastructure powers personalized guidance and secure data sharing for users. The full loop is closed, from question to commercial product.
AI accelerates discovery. Communities fund breakthroughs. Science reaches people.
This is what endto end DeSci looks like, and this is the vision
@BioProtocol is executing on.